Statistics
Publications
131
Citations
18K
H-Index
68
Active since
1978
Koen Andries is an author at Janssen (Belgium) specializing in pharmacology, life sciences, and tuberculosis pharmacotherapy.
Publications per year
1978–2023
131
131
A Diarylquinoline Drug Active on the ATP Synthase of <i>Mycobacterium tuberculosis</i>
Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · Science · 2004 · 2.2K citations · Full text
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch et al. · New England Journal of Medicine · 2009 · 839 citations · Full text
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Rudi Pauwels, Koen Andries, Jan Desmyter et al. · Nature · 1990 · 757 citations
Diarylquinolines target subunit c of mycobacterial ATP synthase
Anil Koul, Najoua Dendouga, Karen Vergauwen et al. · Nature Chemical Biology · 2007 · 548 citations · Full text
1–5 of 131